Status: current, Defined. Date: 30-Nov 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4479031000168118 | Kevzara (sarilumab 200 mg / 1.14 mL) injection, 2 x 1.14 mL syringes (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4479041000168110 | Kevzara 200 mg/1.14 mL injection, 2 x 1.14 mL syringes | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Kevzara 200 mg/1.14 mL injection, 2 x 1.14 mL syringes | Is a | Kevzara 200 mg/1.14 mL injection, 2 x 1.14 mL syringes | true | Inferred relationship | Some | ||
| Kevzara 200 mg/1.14 mL injection, 2 x 1.14 mL syringes | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Kevzara 200 mg/1.14 mL injection, 2 x 1.14 mL syringes | has container type | syringe | true | Inferred relationship | Some | ||
| Kevzara 200 mg/1.14 mL injection, 2 x 1.14 mL syringes | has TP | Kevzara | true | Inferred relationship | Some | ||
| Kevzara 200 mg/1.14 mL injection, 2 x 1.14 mL syringes | has TPUU | Kevzara 200 mg/1.14 mL injection, 1.14 mL syringe | true | Inferred relationship | Some | 1751205931 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Black Triangle Scheme reference set
Containered trade product pack reference set
FHIR